According to GuruFocus Insider Data, the largest CFO sells during the past week were: Visa Inc., SciClone Pharmaceuticals Inc., Validus Holding Ltd. and Amsurg Corp.
Visa Inc. (V, Financial): CFO Byron H. Pollitt Jr. Sold 85,000 Shares
CFO Byron H. Pollitt Jr. sold 85,000 shares of V stock on 06/15/2012 at the average price of $118. Byron H. Pollitt Jr. owns at least 71,473 shares after this. The price of the stock has increased by 5.01% since.
Visa operates the world's largest retail electronic payments network and is one of the most recognized global financial services brands. Visa Inc. has a market cap of $101.71 billion; its shares were traded at around $123.91 with a P/E ratio of 22.23 and P/S ratio of 11.07. The dividend yield of Visa Inc stocks is 0.7%.
For its second quarter of 2012, Visa Inc. reported net income of $1.1 billion – a increase of 23% over the same quarter last year. EPS for class A common stock were $1.60, a 30% increase over prior year quarter. GAAP net operating revenue for the second quarter was $2.6 billion, which represents growth of 15% year over year.
Chairman and CEO Joseph W. Saunders sold 12,420 shares of V stock on 06/21/2012 at the average price of $120.76.
SciClone Pharmaceuticals Inc. (SCLN, Financial): Senior Vice President Finance and CFO Gary Titus Sold 81,607 Shares
Senior Vice President Finance and CFO Gary Titus sold 81,607 shares of SCLN stock on 06/15/2012 at the average price of $7. Gary Titus owns at least 37,095 shares after this. The price of the stock has decreased by 1.14% since.
SciClone Pharmaceuticals Inc. develops and commercializes novel medicines for treating a broad range of the world's most serious diseases. SciClone Pharmaceuticals Inc. has a market cap of $393.03 million; its shares were traded at around $6.92 with a P/E ratio of 11.53 and P/S ratio of 2.94.
SciClone Pharmaceuticals has released its first quarter 2012 results ended March 31, 2012. During this quarter, SciClone reported revenue increase of 81% year over year to $39.2 million. GAAP net income for the company was $8.7 million ($0.15 per share), compared to $3.8 million ($0.08) prior year quarter.
Validus Holdings Ltd. (VR, Financial): President and CFO Joseph E. Consolino Sold 59,866 Shares
President and CFO Joseph E. Consolino sold 59,866 shares of VR stock on 06/19/2012 at the average price of $31.12. Joseph E. Consolino owns at least 264,756 shares after this. The price of the stock has increased by 0.64% since.
Validus Holdings Ltd. has a market cap of $3.11 billion; its shares were traded at around $31.32 with a P/E ratio of 11.27 and P/S ratio of 1.62. The dividend yield of Validus Holdings Ltd. stocks is 3.19%.
For its first quarter ended March 31, 2012, Validus Holdings reported net income of $124.2 million ($1.18 per share), compared to a net loss of $172.4 million ($1.78) in the first quarter of 2011.
Executive Vice President and Chief Risk Officer Stuart W. Mercer, Alok Singh, and multiple other insiders also recently sold shares of VR stock.
Amsurg Corp (AMSG, Financial): Executive Vice President and CFO Claire M. Gulmi Sold 58,145 Shares
Executive VP & CFO Claire M. Gulmi sold 58,145 shares of AMSG stock on 06/15/2012 at the average price of $29.07. Claire M. Gulmi owns at least 96,165 shares after this. The price of the stock has increased by 1.17% since.
AmSurg Corp. is in the business of developing, acquiring and operating practice-based ambulatory surgery centers, in partnerships with physician practice groups, throughout the United States. AmSurg Corp. has a market cap of $930.41 million; its shares were traded at around $29.41 with a P/E ratio of 16.07 and P/S ratio of 1.18. AmSurg Corp. had an annual average earnings growth of 10.8% over the past 10 years. GuruFocus rated AmSurg Corp. the business predictability rank of 3.5-star.
For the complete list of stocks that Sold by their CFOs, go to: Insider Buys.
Visa Inc. (V, Financial): CFO Byron H. Pollitt Jr. Sold 85,000 Shares
CFO Byron H. Pollitt Jr. sold 85,000 shares of V stock on 06/15/2012 at the average price of $118. Byron H. Pollitt Jr. owns at least 71,473 shares after this. The price of the stock has increased by 5.01% since.
Visa operates the world's largest retail electronic payments network and is one of the most recognized global financial services brands. Visa Inc. has a market cap of $101.71 billion; its shares were traded at around $123.91 with a P/E ratio of 22.23 and P/S ratio of 11.07. The dividend yield of Visa Inc stocks is 0.7%.
For its second quarter of 2012, Visa Inc. reported net income of $1.1 billion – a increase of 23% over the same quarter last year. EPS for class A common stock were $1.60, a 30% increase over prior year quarter. GAAP net operating revenue for the second quarter was $2.6 billion, which represents growth of 15% year over year.
Chairman and CEO Joseph W. Saunders sold 12,420 shares of V stock on 06/21/2012 at the average price of $120.76.
SciClone Pharmaceuticals Inc. (SCLN, Financial): Senior Vice President Finance and CFO Gary Titus Sold 81,607 Shares
Senior Vice President Finance and CFO Gary Titus sold 81,607 shares of SCLN stock on 06/15/2012 at the average price of $7. Gary Titus owns at least 37,095 shares after this. The price of the stock has decreased by 1.14% since.
SciClone Pharmaceuticals Inc. develops and commercializes novel medicines for treating a broad range of the world's most serious diseases. SciClone Pharmaceuticals Inc. has a market cap of $393.03 million; its shares were traded at around $6.92 with a P/E ratio of 11.53 and P/S ratio of 2.94.
SciClone Pharmaceuticals has released its first quarter 2012 results ended March 31, 2012. During this quarter, SciClone reported revenue increase of 81% year over year to $39.2 million. GAAP net income for the company was $8.7 million ($0.15 per share), compared to $3.8 million ($0.08) prior year quarter.
Validus Holdings Ltd. (VR, Financial): President and CFO Joseph E. Consolino Sold 59,866 Shares
President and CFO Joseph E. Consolino sold 59,866 shares of VR stock on 06/19/2012 at the average price of $31.12. Joseph E. Consolino owns at least 264,756 shares after this. The price of the stock has increased by 0.64% since.
Validus Holdings Ltd. has a market cap of $3.11 billion; its shares were traded at around $31.32 with a P/E ratio of 11.27 and P/S ratio of 1.62. The dividend yield of Validus Holdings Ltd. stocks is 3.19%.
For its first quarter ended March 31, 2012, Validus Holdings reported net income of $124.2 million ($1.18 per share), compared to a net loss of $172.4 million ($1.78) in the first quarter of 2011.
Executive Vice President and Chief Risk Officer Stuart W. Mercer, Alok Singh, and multiple other insiders also recently sold shares of VR stock.
Amsurg Corp (AMSG, Financial): Executive Vice President and CFO Claire M. Gulmi Sold 58,145 Shares
Executive VP & CFO Claire M. Gulmi sold 58,145 shares of AMSG stock on 06/15/2012 at the average price of $29.07. Claire M. Gulmi owns at least 96,165 shares after this. The price of the stock has increased by 1.17% since.
AmSurg Corp. is in the business of developing, acquiring and operating practice-based ambulatory surgery centers, in partnerships with physician practice groups, throughout the United States. AmSurg Corp. has a market cap of $930.41 million; its shares were traded at around $29.41 with a P/E ratio of 16.07 and P/S ratio of 1.18. AmSurg Corp. had an annual average earnings growth of 10.8% over the past 10 years. GuruFocus rated AmSurg Corp. the business predictability rank of 3.5-star.
For the complete list of stocks that Sold by their CFOs, go to: Insider Buys.
